Budesonide was included in the European Baseline Series in 2000 as the most suitable marker for CS hypersensitivity. In the last 2 decades a decreasing trend of budesonide allergy was observed.
Patch testing of budesonide in Italy: the SIDAPA baseline series experience, 2018-2019
Patruno, Cataldo;
2021-01-01
Abstract
Budesonide was included in the European Baseline Series in 2000 as the most suitable marker for CS hypersensitivity. In the last 2 decades a decreasing trend of budesonide allergy was observed.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
